Correlation Between Plandai Biotech and Strategic Management

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Plandai Biotech and Strategic Management at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Plandai Biotech and Strategic Management into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Plandai Biotech and Strategic Management and, you can compare the effects of market volatilities on Plandai Biotech and Strategic Management and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Plandai Biotech with a short position of Strategic Management. Check out your portfolio center. Please also check ongoing floating volatility patterns of Plandai Biotech and Strategic Management.

Diversification Opportunities for Plandai Biotech and Strategic Management

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Plandai and Strategic is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Plandai Biotech and Strategic Management and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Strategic Management and and Plandai Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Plandai Biotech are associated (or correlated) with Strategic Management. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Strategic Management and has no effect on the direction of Plandai Biotech i.e., Plandai Biotech and Strategic Management go up and down completely randomly.

Pair Corralation between Plandai Biotech and Strategic Management

Given the investment horizon of 90 days Plandai Biotech is expected to generate 8.93 times more return on investment than Strategic Management. However, Plandai Biotech is 8.93 times more volatile than Strategic Management and. It trades about 0.12 of its potential returns per unit of risk. Strategic Management and is currently generating about -0.01 per unit of risk. If you would invest  0.04  in Plandai Biotech on October 15, 2024 and sell it today you would lose (0.03) from holding Plandai Biotech or give up 75.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Plandai Biotech  vs.  Strategic Management and

 Performance 
       Timeline  
Plandai Biotech 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Plandai Biotech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating basic indicators, Plandai Biotech disclosed solid returns over the last few months and may actually be approaching a breakup point.
Strategic Management and 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Strategic Management and has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Strategic Management is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Plandai Biotech and Strategic Management Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Plandai Biotech and Strategic Management

The main advantage of trading using opposite Plandai Biotech and Strategic Management positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Plandai Biotech position performs unexpectedly, Strategic Management can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Strategic Management will offset losses from the drop in Strategic Management's long position.
The idea behind Plandai Biotech and Strategic Management and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio